Get the Stockscreener App
70.18
4.65%
-3.42
Lantheus Holdings Inc stock is traded at $70.18, with a volume of 1.35M.
It is down -4.65% in the last 24 hours and down -11.15% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$73.60
Open:
$74.47
24h Volume:
1.35M
Relative Volume:
1.17
Market Cap:
$4.86B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
11.68
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-13.69%
1M Performance:
-11.15%
6M Performance:
-23.28%
1Y Performance:
-39.36%
1-Day Range:
$69.88
$74.47
1-Week Range:
$69.12
$83.32
52-Week Range:
$69.12
$118.71
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
70.18 | 5.63B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
148.60 | 68.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 46.36B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.60 | 44.74B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.06 | 18.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.01 | 13.33B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
What drives Lantheus Holdings Inc. stock priceAccelerated capital growth - PrintWeekIndia
What analysts say about Lantheus Holdings Inc. stockFree Trading Strategy Suggestions - Jammu Links News
Is Lantheus Holdings Inc. a good long term investmentOutstanding investment returns - Jammu Links News
Lantheus Holdings Inc. Stock Analysis and ForecastAccelerated profit realization - Jammu Links News
Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Lantheus sinks 8% as CMS wants to maintain reimbursement model for radiopharmaceuticals - MSN
Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com
Radiopharmaceutical Renaissance: Lantheus Navigates CMS Policy Shifts to Secure Dominance in Diagnostic Imaging - AInvest
Lantheus Holdings (LNTH) Plunges 14.94% Amid CMS Decision - AInvest
Lantheus Holdings (LNTH) Stock Falls as CMS Retains Current Reim - GuruFocus
Why Is Lantheus Stock Trading Lower On Wednesday? - Benzinga
Why Lantheus (LNTH) Stock Is Down Today - TradingView
Lantheus (LNTH) Shares Decline Amid Market Activity | LNTH Stock News - GuruFocus
Lantheus Plummets to 52-Week Low: Is the Bottom in Sight or More Pain Ahead? - AInvest
Lantheus Holdings stock reaches 52-week low at $72.92 By Investing.com - Investing.com South Africa
Lantheus Holdings stock reaches 52-week low at $72.92 - Investing.com
Lantheus (LNTH) Likely to Maintain Pylarify Reimbursement Status in 2026 | LNTH Stock News - GuruFocus
Lantheus (LNTH) Faces Setback with CMS Reimbursement Decision | - GuruFocus
Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging - Radiology Business
Lantheus Holdings: Navigating Geopolitical Storms to Capture Precision Diagnostics Growth - AInvest
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance
(LNTH) Investment Report - news.stocktradersdaily.com
Lantheus Holdings’ SWOT analysis: theranostics leader faces growth challenges - Investing.com
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2025 Earnings Call Transcript - MSN
Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Could The Market Be Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Its Attractive Financial Prospects? - 富途牛牛
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment - MSN
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - Insider Monkey
Lantheus Holdings (LNTH): A Breakthrough in Fibrosis Imaging and a Compelling Investment Thesis - AInvest
Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting - MSN
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q1 - Yahoo Finance
Alzheimer’s Association Partners with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path By Investing.com - Investing.com South Africa
(LNTH) Technical Data - news.stocktradersdaily.com
The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st
Lantheus Announces Presentations to be featured at the 2025 Soci - GuruFocus
Insider Sell: Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) - GuruFocus
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - The Manila Times
Lantheus Holdings, Inc. to Present New Data on Oncology Radiodiagnostics at 2025 SNMMI Annual Meeting - Nasdaq
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and ... - Eagle-Tribune
Lantheus Unveils Breakthrough Cancer Diagnostic Results at SNMMI 2025: Multiple Studies Show Promise - Stock Titan
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare - Investing.com
Transcript : Lantheus Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Lantheus to Present at the 2025 Truist Securities MedTech Conference - The Manila Times
Lantheus CEO Reveals Growth Strategy: Key Insights Coming at Truist MedTech Conference - Stock Titan
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)? - Yahoo Finance
Investor Network: Lantheus Holdings Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Lantheus Holdings Inc to Host Earnings Call - ACCESS Newswire
Lantheus to Present at the Goldman Sachs 46th Annual Global Heal - GuruFocus
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):